Article Type
Case Series
Published
This case series represents the first clinical real-life experience of rapid and successful management of facial psoriasis with bimekizumab in six patients.
Case Series
This case series represents the first clinical real-life experience of rapid and successful management of facial psoriasis with bimekizumab in six patients.
Review
In this narrative review, the authors evaluate available data on the use of an innovative aerosol foam formulation of calcipotriol plus betamethasone dipropionate (Cal/BD) to treat patients with psoriasis and scalp involvement.
Original Research
This study aimed to evaluate the effectiveness of tildrakizumab in treating moderate-to-severe psoriasis within a real-world setting over a 52-week period in Portugal.
Review
This multicentre, retrospective study evaluates the efficacy and safety of risankizumab in a population of psoriatic patients with palmoplantar involvement over a 52-week treatment period.
Original Research
This study characterizes the sensorial attributes of the calcipotriol
(CAL) and betamethasone dipropionate (BDP) polyaphron dispersion cream vehicle and compares them with the sensorial attributes of conventional formulations for psoriasis such as an ointment and an oleogel product.